Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,117 | 281 | 99.8% |
| Education | $17.26 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,406 | 117 | $0 (2024) |
| QOL Medical, LLC | $764.48 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $600.16 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $509.33 | 19 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $373.45 | 15 | $0 (2024) |
| GENZYME CORPORATION | $356.83 | 7 | $0 (2024) |
| RedHill Biopharma Inc. | $296.53 | 16 | $0 (2024) |
| Celgene Corporation | $293.28 | 14 | $0 (2024) |
| Braintree Laboratories, Inc. | $265.51 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $264.99 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,937 | 104 | ABBVIE INC. ($883.87) |
| 2023 | $1,831 | 76 | ABBVIE INC. ($383.61) |
| 2022 | $1,831 | 81 | ABBVIE INC. ($813.23) |
| 2021 | $535.95 | 21 | AbbVie Inc. ($325.00) |
All Payment Transactions
282 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $45.49 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $24.00 | General |
| 12/18/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/13/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $21.60 | General |
| Category: GI | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.95 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.27 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $44.72 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $26.28 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $36.59 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.64 | General |
| Category: Immunology | ||||||
| 10/25/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $30.04 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: LIVER DISEASE | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $82.27 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Immunology | ||||||
| 10/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $36.88 | General |
| Category: Immunology | ||||||
| 10/08/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $22.71 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $66.57 | General |
| Category: Immunology | ||||||
| 09/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $43.93 | General |
| Category: Immunology | ||||||
| 09/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: INTERNAL MEDICINE | ||||||
About Dr. Daniel Perl, MD
Dr. Daniel Perl, MD is a Gastroenterology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2015. The National Provider Identifier (NPI) number assigned to this provider is 1497133433.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Perl, MD has received a total of $7,135 in payments from pharmaceutical and medical device companies, with $2,937 received in 2024. These payments were reported across 282 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($7,117).
Practice Information
- Specialty Gastroenterology
- Location New York, NY
- Active Since 05/11/2015
- Last Updated 03/22/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1497133433
Products in Payments
- DUPIXENT (Biological) $866.16
- RINVOQ (Biological) $831.01
- SUCRAID (Drug) $677.69
- ZEPOSIA (Drug) $558.27
- SKYRIZI (Biological) $505.78
- HUMIRA (Biological) $466.88
- STELARA (Biological) $401.98
- ENTYVIO (Biological) $373.45
- VIBERZI (Drug) $238.58
- Talicia (Drug) $233.63
- CREON (Drug) $221.42
- TREMFYA (Drug) $198.18
- IBSRELA (Drug) $166.91
- SUTAB (Drug) $164.34
- Linzess (Drug) $153.45
- LINZESS (Drug) $112.51
- XELJANZ (Drug) $107.38
- CLENPIQ (Drug) $96.15
- Sucraid (Drug) $86.79
- APRETUDE (Biological) $60.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in New York
Arthur Kornbluth, Md, MD
Gastroenterology — Payments: $2.4M
Dr. David Carr-Locke, Md Frcp Facg Masge, MD FRCP FACG MASGE
Gastroenterology — Payments: $2.3M
Jean-Frederic Colombel, M.d, M.D
Gastroenterology — Payments: $1.1M
Dr. Bruce Sands, Md, MD
Gastroenterology — Payments: $1.0M
Ellen Scherl, Md, MD
Gastroenterology — Payments: $880,329
Sonal Kumar, Md, MD
Gastroenterology — Payments: $769,554